Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Peters

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Blut|January 1, 1988
High-dose cytosine arabinoside: pharmacological and clinical aspectsW G Peters, L P Colly, R Willemze
Cancer Research|August 1, 1986
Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemiaL P Colly, W G Peters, R Willemze
British Journal of Haematology|April 1, 1987
Short-term high-dose treatment in bad-risk ALL and lymphoblastic NHLR Willemze, W G Peters, L P Colly
Nederlands Tijdschrift Voor Geneeskunde|June 22, 1985
[Linitis plastica, a rare disease picture]W G Peters, P Spoelstra, J L Terpstra
Seminars in Oncology|June 1, 1987
Intermediate and high-dose cytosine arabinoside-containing regimens for induction and consolidation therapy for patients with acute lymphoblastic leukemia and lymphoblastic non-Hodgkin's lymphoma: the Leyden experience and review of the literatureW G Peters, R Willemze, L P Colly
The Netherlands Journal of Medicine|February 1, 1992
Cutaneous leukocytoclastic vasculitis in relation to streptokinaseA J Bindels, T L See, W G Peters
Nederlands Tijdschrift Voor Geneeskunde|June 20, 1992
[An overlooked lymphoma of the stomach can sometimes have serious consequences]J C Kluin-Nelemans, W G Peters, M Kluin
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1985
[Ophthalmological side effects of the use of cytostatic agents]W G Peters, W Swart, L P Colly, et al.
British Journal of Haematology|April 1, 1985
Prediction of response of acute non-lymphocytic leukaemia to therapy with 'high dose' cytosine arabinosideW G Peters, R Willemze, L P Colly, et al.
Blut|August 1, 1988
Day-6 bone marrow aspirate for the prediction of response to remission induction therapy for acute myelogenous leukaemiaW G Peters, R Willemze, F E Zwaan, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Blut|January 1, 1988
High-dose cytosine arabinoside: pharmacological and clinical aspectsW G Peters, L P Colly, R Willemze
Cancer Research|August 1, 1986
Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemiaL P Colly, W G Peters, R Willemze
British Journal of Haematology|April 1, 1987
Short-term high-dose treatment in bad-risk ALL and lymphoblastic NHLR Willemze, W G Peters, L P Colly
Nederlands Tijdschrift Voor Geneeskunde|June 22, 1985
[Linitis plastica, a rare disease picture]W G Peters, P Spoelstra, J L Terpstra
Seminars in Oncology|June 1, 1987
Intermediate and high-dose cytosine arabinoside-containing regimens for induction and consolidation therapy for patients with acute lymphoblastic leukemia and lymphoblastic non-Hodgkin's lymphoma: the Leyden experience and review of the literatureW G Peters, R Willemze, L P Colly
The Netherlands Journal of Medicine|February 1, 1992
Cutaneous leukocytoclastic vasculitis in relation to streptokinaseA J Bindels, T L See, W G Peters
Nederlands Tijdschrift Voor Geneeskunde|June 20, 1992
[An overlooked lymphoma of the stomach can sometimes have serious consequences]J C Kluin-Nelemans, W G Peters, M Kluin
Nederlands Tijdschrift Voor Geneeskunde|December 28, 1985
[Ophthalmological side effects of the use of cytostatic agents]W G Peters, W Swart, L P Colly, et al.
British Journal of Haematology|April 1, 1985
Prediction of response of acute non-lymphocytic leukaemia to therapy with 'high dose' cytosine arabinosideW G Peters, R Willemze, L P Colly, et al.
Blut|August 1, 1988
Day-6 bone marrow aspirate for the prediction of response to remission induction therapy for acute myelogenous leukaemiaW G Peters, R Willemze, F E Zwaan, et al.
Pageof 4